Michael King
Stock Analyst at Rodman & Renshaw
(0.82)
# 3,783
Out of 4,408 analysts
343
Total ratings
39.8%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYNB Kyntra Bio | Initiated Coverage: Buy | $30 | $7.13 | +320.76% | 1 | Jun 9, 2026 | |
| BOLT Bolt Biotherapeutics | Initiated Coverage: Buy | $22 | $4.56 | +382.46% | 1 | May 28, 2026 | |
| SANA Sana Biotechnology | Initiated Coverage: Buy | $16 | $2.68 | +497.01% | 1 | May 11, 2026 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $150 → $7 | $2.32 | +201.72% | 7 | Apr 15, 2026 | |
| BTAI BioXcel Therapeutics | Initiated Coverage: Buy | $17 | $1.14 | +1,391.23% | 1 | Mar 17, 2026 | |
| KPTI Karyopharm Therapeutics | Initiated Coverage: Buy | $22 → $28 | $9.50 | +194.89% | 8 | Mar 9, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $17 | $14.85 | +14.48% | 1 | Mar 9, 2026 | |
| XAIR Beyond Air | Initiated Coverage: Buy | $5 | $0.371 | +1,247.71% | 1 | Jan 20, 2026 | |
| JSPR Jasper Therapeutics | Initiated Coverage: Buy | $69 → $17 | $0.4576 | +3,615.03% | 10 | Jan 13, 2026 | |
| BCAB BioAtla | Initiated Coverage: Buy | $200 | $3.86 | +5,081.35% | 1 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 → $8 | $1.17 | +583.76% | 12 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.94 | +751.06% | 1 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.26 | +534.92% | 1 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.88 | n/a | 17 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $10.93 | n/a | 5 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $862 | $612.14 | n/a | 40 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $53.13 | n/a | 26 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $17 | $0.0002 | n/a | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $14.31 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.3 | $3.30 | n/a | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.3 | $0.381 | n/a | 17 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $12.33 | n/a | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $123 → $116 | $12.11 | n/a | 25 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $207 → $304 | $282.85 | n/a | 17 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 → $10 | $2.03 | n/a | 6 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.000001 | n/a | 9 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $0.0131 | n/a | 4 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $44.18 | n/a | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $56.07 | n/a | 15 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $24.53 | n/a | 3 | Mar 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $33.10 | n/a | 6 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $8.31 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 → $100 | $6.01 | n/a | 4 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 | $29.46 | n/a | 12 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.04 | n/a | 1 | Apr 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $108.81 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $69 | $49.80 | n/a | 1 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $2.50 | n/a | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.41 | n/a | 3 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $9.05 | n/a | 4 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $17 | $0.0003 | n/a | 6 | Feb 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $3.37 | n/a | 5 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $36 | $893.52 | n/a | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0001 | n/a | 4 | Sep 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $0.9245 | n/a | 3 | Apr 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $2.77 | n/a | 1 | Mar 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.90 | n/a | 2 | Dec 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.78 | n/a | 4 | Nov 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.25 | n/a | 3 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.87 | n/a | 6 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.69 | n/a | 3 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.02 | n/a | 4 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.26 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.10 | n/a | 1 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.99 | n/a | 1 | Feb 25, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.0001 | n/a | 1 | May 19, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $0.0011 | n/a | 1 | Mar 28, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $23.48 | n/a | 1 | Feb 18, 2010 |
Kyntra Bio
Jun 9, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $7.13
Upside: +320.76%
Bolt Biotherapeutics
May 28, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $4.56
Upside: +382.46%
Sana Biotechnology
May 11, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $2.68
Upside: +497.01%
TuHURA Biosciences
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $150 → $7
Current: $2.32
Upside: +201.72%
BioXcel Therapeutics
Mar 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $1.14
Upside: +1,391.23%
Karyopharm Therapeutics
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $22 → $28
Current: $9.50
Upside: +194.89%
Elicio Therapeutics
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $14.85
Upside: +14.48%
Beyond Air
Jan 20, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.371
Upside: +1,247.71%
Jasper Therapeutics
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $69 → $17
Current: $0.4576
Upside: +3,615.03%
BioAtla
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $200
Current: $3.86
Upside: +5,081.35%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $32 → $8
Current: $1.17
Upside: +583.76%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $0.94
Upside: +751.06%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.26
Upside: +534.92%
Jun 26, 2023
Maintained: Buy
Price Target: $11
Current: $3.88
Upside: n/a
May 18, 2023
Reiterated: Buy
Price Target: $6
Current: $10.93
Upside: n/a
May 1, 2023
Reiterated: Buy
Price Target: $862
Current: $612.14
Upside: n/a
Apr 28, 2023
Reiterated: Buy
Price Target: $24
Current: $53.13
Upside: n/a
Apr 27, 2023
Maintained: Buy
Price Target: $10 → $17
Current: $0.0002
Upside: n/a
Apr 26, 2023
Initiated Coverage: Buy
Price Target: $25
Current: $14.31
Upside: n/a
Mar 28, 2023
Reiterated: Buy
Price Target: $8.3
Current: $3.30
Upside: n/a
Mar 24, 2023
Reiterated: Buy
Price Target: $8.3
Current: $0.381
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $42
Current: $12.33
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: $123 → $116
Current: $12.11
Upside: n/a
Feb 21, 2023
Initiated Coverage: Buy
Price Target: $207 → $304
Current: $282.85
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $11 → $10
Current: $2.03
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $9
Current: $0.000001
Upside: n/a
Mar 29, 2022
Reiterated: Buy
Price Target: $25 → $28
Current: $0.0131
Upside: n/a
Mar 23, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $44.18
Upside: n/a
Mar 22, 2022
Maintained: Buy
Price Target: $46
Current: $56.07
Upside: n/a
Mar 18, 2022
Reiterated: Buy
Price Target: $20
Current: $24.53
Upside: n/a
Mar 16, 2022
Maintained: Buy
Price Target: $31
Current: $33.10
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $36
Current: $8.31
Upside: n/a
Mar 11, 2022
Reiterated: Buy
Price Target: $125 → $100
Current: $6.01
Upside: n/a
Mar 3, 2022
Reiterated: Buy
Price Target: $96
Current: $29.46
Upside: n/a
Apr 16, 2018
Reiterated: Buy
Price Target: $11
Current: $2.04
Upside: n/a
Mar 19, 2018
Reiterated: Buy
Price Target: $9
Current: $108.81
Upside: n/a
Mar 8, 2018
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 8, 2018
Initiated Coverage: Buy
Price Target: $69
Current: $49.80
Upside: n/a
Mar 7, 2018
Maintained: Buy
Price Target: $67
Current: $2.50
Upside: n/a
Feb 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $10.41
Upside: n/a
Feb 15, 2018
Reiterated: Buy
Price Target: $24
Current: $9.05
Upside: n/a
Feb 6, 2018
Reiterated: Buy
Price Target: $12 → $17
Current: $0.0003
Upside: n/a
Jan 17, 2018
Reiterated: Buy
Price Target: $3
Current: $3.37
Upside: n/a
Nov 13, 2017
Maintained: Buy
Price Target: $33 → $36
Current: $893.52
Upside: n/a
Sep 28, 2017
Upgraded: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 26, 2017
Maintained: Buy
Price Target: $21
Current: $0.9245
Upside: n/a
Mar 22, 2017
Initiated Coverage: Buy
Price Target: $11
Current: $2.77
Upside: n/a
Dec 14, 2016
Downgraded: Hold
Price Target: n/a
Current: $3.90
Upside: n/a
Nov 21, 2016
Reiterated: Buy
Price Target: n/a
Current: $17.78
Upside: n/a
Nov 11, 2016
Reiterated: Buy
Price Target: n/a
Current: $18.25
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: n/a
Current: $5.87
Upside: n/a
Nov 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $5.69
Upside: n/a
Aug 18, 2016
Downgraded: Hold
Price Target: n/a
Current: $2.02
Upside: n/a
Aug 8, 2016
Reiterated: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $4.10
Upside: n/a
Feb 25, 2015
Reiterated: Hold
Price Target: n/a
Current: $22.99
Upside: n/a
May 19, 2014
Reiterated: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Mar 28, 2012
Maintained: Buy
Price Target: $24
Current: $0.0011
Upside: n/a
Feb 18, 2010
Downgraded: Hold
Price Target: n/a
Current: $23.48
Upside: n/a